Hey anon, Thanks so much for writing. Several years of medication can certainly make us wonder what's in store for us. We asked the wonderful Lillie Schockney, RN., BS., MAS, who holds many titles with Johns Hopkins School of Medicine including professor of breast cancer and professor of surgery and gynecology as well as administrative director for the Avon Foundation Breast Center. Here was her response:
"Clinical trials haven't completed yet to tell us the next steps. So currently, you should consider your treatment completed when you've hit that 10 year mark. The risk of recurrence is quite low at a decade. Down the road, there may be other hormonal therapies or even decisions to continue on Letrozole but currently no hormonal therapy is recommended passed the time frame you have accrued."
Comment Reply
Hey anon, Thanks so much for writing. Several years of medication can certainly make us wonder what's in store for us. We asked the wonderful Lillie Schockney, RN., BS., MAS, who holds many titles with Johns Hopkins School of Medicine including professor of breast cancer and professor of surgery and gynecology as well as administrative director for the Avon Foundation Breast Center. Here was her response:
"Clinical trials haven't completed yet to tell us the next steps. So currently, you should consider your treatment completed when you've hit that 10 year mark. The risk of recurrence is quite low at a decade. Down the road, there may be other hormonal therapies or even decisions to continue on Letrozole but currently no hormonal therapy is recommended passed the time frame you have accrued."
March 11, 2009 - 3:10pmThis Comment
Reply